_2-sml.jpg)
The business case for clinical governance
As the COVID-19 pandemic continues to cast a shadow over the health of the world, we continue to learn about clinical governance at scale. We have previously drawn analogies to Australian government responses with clinical governance principles - however the parallels don’t stop there. Across the world, the economic impact of the pandemic has been palpable and is illustrative of the co-dependent relationship between health and money, where better health outcomes are known to correlate with better economic outcomes.
